Growth factors in idiopathic pulmonary fibrosis: relative roles

Allen, JT and Spiteri, MA 2002, 'Growth factors in idiopathic pulmonary fibrosis: relative roles' , Respiratory Research, 3 (1) , pp. 13-22.

Preview

PDF (Publisher version) Download (1MB) | Preview

Abstract

Treatment of idiopathic pulmonary fibrosis patients has evolved very slowly; the fundamental approach of corticosteroids alone or in combination with other immunosuppressive agents has had little impact on long-term survival. The continued use of corticosteroids is justified because of the lack of a more effective alternative. Current research indicates that the mechanisms driving idiopathic pulmonary fibrosis reflect abnormal, dysregulated wound healing within the lung, involving increased activity and possibly exaggerated responses by a spectrum of profibrogenic growth factors. An understanding of the roles of these growth factors, and the way in which they modulate events at cellular level, could lead to more targeted therapeutic strategies, improving patients' quality of life and survival.

Item Type:	Article
Themes:	Subjects / Themes > R Medicine > R Medicine (General) Health and Wellbeing
Schools:	Schools > School of Environment and Life Sciences Schools > School of Environment and Life Sciences > Ecosystems and Environment Research Centre
Journal or Publication Title:	Respiratory Research
Publisher:	BioMed Central
Refereed:	Yes
ISSN:	14659921
Related URLs:	Publisher Publication
Depositing User:	H Kenna
Date Deposited:	07 Aug 2007 08:32
Last Modified:	16 Feb 2022 07:34
URI:	https://usir.salford.ac.uk/id/eprint/123

Actions (login required)

Edit record (repository staff only)